All Clinical Trials

Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us

Clinical trials
Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
Apply

Ipilimumab & NivolumabNeoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma

Basic information

Step 1/5

Provide your basic information

Age

ZIP code

Terms of use Privacy policy

All Clinical Trials 2026All Rights reservedPrivacy Policy Terms of Use

Locations Texas Arizona California New York Massachusetts Florida New Jersey Utah All locationsConditions Oncology Alzheimer's Diabetes Multiple Sclerosis Arthritis Hepatitis C COPD Depression All conditionsTreatments Weight Loss Stem Cells Vaccines Sleep Apnea Medical Devices IVF Dental Drug Addiction All treatmentsInstitutions Pfizer Moderna NIH UCLA Stanford M.D. Anderson Labcorp All institutionsResourcesBlog FAQ Medical advisors

Terms of use Privacy policy

All Clinical Trials 2026All Rights reservedPrivacy Policy Terms of Use